Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

SkyBridge Capital: What's behind the "best incubation environment in 30 years"

Friday, March 19, 2010

From Kirsten Bischoff, Opalesque New York:

Hunting for seed money has always been an active part of asset-raising within the hedge fund community. Typically an investment space reserved for those familiar with and enthusiastic about developing promising talent, seed money often came from successful managers who helped startups spinning out of their own portfolio teams (ie, Julian Robertson's Tiger cubs). Over recent years seeding has also taken the shape of formal investment funds, with an asset base drawn mainly from high net worth individuals and family offices. However, in today's hedge fund environment these seed funds are finding investors outside their normal base are very interested in finding a way to fully participate in the industry as it begins to rebuild.

"The seeding model has gained mainstream acceptance," says Anthony Scaramucci, Managing Partner at SkyBridge Capital. SkyBridge, which launched in 2005 oversees the annual SkyBridge Alternatives (SALT) Conference every May in Las Vegas, NV, and was most recently revealed in the WSJ to be in advanced acquisition discussions to purchase Citi's $4bn fund of funds business. (Source).

Seed funds have two specific factors on their side: current launch quality and added manager control The fina......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its